180 related articles for article (PubMed ID: 6692653)
1. Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calcium.
Ralston SH; Fogelman I; Gardner MD; Dryburgh FJ; Cowan RA; Boyle IT
Clin Sci (Lond); 1984 Feb; 66(2):187-91. PubMed ID: 6692653
[TBL] [Abstract][Full Text] [Related]
2. Influence of urinary sodium excretion on the clinical assessment of renal tubular calcium reabsorption in hypercalcaemic man.
Ralston SH; Gardner MD; Dryburgh FJ; Cowan RA; Boyle IT
J Clin Pathol; 1986 Jun; 39(6):641-6. PubMed ID: 3722417
[TBL] [Abstract][Full Text] [Related]
3. Comparison of intestinal calcium absorption and circulating 1,25-dihydroxyvitamin D levels in malignancy-associated hypercalcaemia and primary hyperparathyroidism.
Ralston SH; Cowan RA; Gardner MD; Fraser WD; Marshall E; Boyle IT
Clin Endocrinol (Oxf); 1987 Mar; 26(3):281-91. PubMed ID: 3652475
[TBL] [Abstract][Full Text] [Related]
4. Familial benign hypercalcaemia. Study of a large family.
Menko FH; Bijvoet OL; Fronen JL; Sandler LM; Adami S; O'Riordan JL; Schopman W; Heynen G
Q J Med; 1983; 52(206):120-40. PubMed ID: 6310672
[TBL] [Abstract][Full Text] [Related]
5. Clinical studies on phosphate handling in hypercalcaemia.
Wikström B; Ljunghall S; Wide L; Akerström G
Acta Med Scand; 1982; 212(6):413-20. PubMed ID: 6297262
[TBL] [Abstract][Full Text] [Related]
6. Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.
Ralston SH; Fogelman I; Gardiner MD; Boyle IT
Br Med J (Clin Res Ed); 1984 May; 288(6428):1405-8. PubMed ID: 6426577
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of bone resorption and renal tubular reabsorption of calcium and phosphate in malignant and nonmalignant hypercalcemia.
Buchs B; Rizzoli R; Bonjour JP
Bone; 1991; 12(1):47-56. PubMed ID: 2054236
[TBL] [Abstract][Full Text] [Related]
8. Incidence, causes and mechanism of hypercalcaemia in a hospital population in Hong Kong.
Shek CC; Natkunam A; Tsang V; Cockram CS; Swaminathan R
Q J Med; 1990 Dec; 77(284):1277-85. PubMed ID: 2290921
[TBL] [Abstract][Full Text] [Related]
9. Tubular maximum for calcium reabsorption: lack of diagnostic usefulness in primary hyperparathyroidism and familial hypocalciuric hypercalcaemia.
Kent GN; Bhagat CI; Garcia-Webb P; Gutteridge DH
Clin Chim Acta; 1987 Jul; 166(2-3):155-61. PubMed ID: 3621596
[TBL] [Abstract][Full Text] [Related]
10. Humoral hypercalcaemia of malignancy: metabolic and histomorphometric studies during surgical management of the primary tumour.
Ralston SH; Boyce BF; Cowan RA; Gardner MD; Dryburgh FJ; Boyle IT
Q J Med; 1986 Mar; 58(227):325-35. PubMed ID: 3016790
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone-related protein-(1--36) stimulates renal tubular calcium reabsorption in normal human volunteers: implications for the pathogenesis of humoral hypercalcemia of malignancy.
Syed MA; Horwitz MJ; Tedesco MB; Garcia-Ocaña A; Wisniewski SR; Stewart AF
J Clin Endocrinol Metab; 2001 Apr; 86(4):1525-31. PubMed ID: 11297578
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcaemia in two hospital populations.
Walls J; Ratcliffe WA; Howell A; Bundred NJ
Clin Endocrinol (Oxf); 1994 Oct; 41(4):407-13. PubMed ID: 7955450
[TBL] [Abstract][Full Text] [Related]
13. Response to intravenous bisphosphonate therapy in hypercalcaemic patients with and without bone metastases: the role of parathyroid hormone-related protein.
Walls J; Ratcliffe WA; Howell A; Bundred NJ
Br J Cancer; 1994 Jul; 70(1):169-72. PubMed ID: 8018531
[TBL] [Abstract][Full Text] [Related]
14. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
[TBL] [Abstract][Full Text] [Related]
15. Familial hypocalciuric hypercalcaemia: evidence for continued enhanced renal tubular reabsorption of calcium following total parathyroidectomy.
Davies M; Adams PH; Lumb GA; Berry JL; Loveridge N
Acta Endocrinol (Copenh); 1984 Aug; 106(4):499-504. PubMed ID: 6475456
[TBL] [Abstract][Full Text] [Related]
16. Malignancy-associated hypercalcaemia: relationship between mechanisms of hypercalcaemia and response to antihypercalcaemic therapy.
Ralston SH; Gardner MD; Jenkins AS; McKillop JH; Boyle IT
Bone Miner; 1987 May; 2(3):227-42. PubMed ID: 2974309
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone-related protein of malignancy: immunohistochemical and biochemical studies in normocalcaemic and hypercalcaemic patients with cancer.
Ralston SH; Danks J; Hayman J; Fraser WD; Stewart CS; Martin TJ
J Clin Pathol; 1991 Jun; 44(6):472-6. PubMed ID: 2066425
[TBL] [Abstract][Full Text] [Related]
18. Treatment of the hypercalcaemia of malignancy with intravenous clodronate.
Urwin GH; Yates AJ; Gray RE; Hamdy NA; McCloskey EV; Preston FE; Greaves M; Neil FE; Kanis JA
Bone; 1987; 8 Suppl 1():S43-51. PubMed ID: 2961354
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of malignant hypercalcaemia in carcinoma of the breast.
Percival RC; Yates AJ; Gray RE; Galloway J; Rogers K; Neal FE; Kanis JA
Br Med J (Clin Res Ed); 1985 Sep; 291(6498):776-9. PubMed ID: 3929936
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of calcitonin by corticosteroids during the treatment of the hypercalcaemia of malignancy.
Hosking DJ; Stone MD; Foote JW
Eur J Clin Pharmacol; 1990; 38(1):37-41. PubMed ID: 2328745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
